NDUFAF7

NDUFAF7 is a mitochondrial matrix S-adenosylmethionine-dependent protein arginine methyltransferase that acts as an early assembly factor for respiratory complex I (PMID:24089531, PMID:24838397). Its defining catalytic activity is the symmetric dimethylation of the ω-N(G),N(G') atoms of Arg-85 in the complex I subunit NDUFS2, a modification deposited after NDUFS2 has incorporated into a nascent complex I intermediate and which stabilizes an early ~400-kDa subcomplex forming the nucleus of the peripheral arm and its junction with the membrane arm (PMID:24089531, PMID:24838397). Loss of NDUFAF7 destabilizes this intermediate: knockdown in human fibroblasts triggers rapid AFG3L2-dependent turnover of newly synthesized ND1 and lowers steady-state NDUFS2, NDUFS1, and NDUFA9, while a methyltransferase-dead G124V mutant fails to support complex I assembly, establishing that catalytic activity is required for biogenesis (PMID:24838397). The factor is essential in vertebrates, as germline disruption is early embryonic lethal in mice and morpholino knockdown produces a complex I defect in zebrafish (PMID:24838397). Crystal structures of the Dictyostelium ortholog MidA reveal a methyltransferase catalytic core with a regulatory loop domain, and binding assays show that methylation weakens the MidA–NDUFS2 interaction, defining a methylation-controlled substrate-release mechanism conserved from proteobacteria to humans (PMID:30134162). A missense variant (D266E) impairs complex I activity, lowers cellular ATP, and disrupts proper mitochondrial localization of the protein, linking NDUFAF7 dysfunction to mitochondrial bioenergetic deficiency (PMID:28837730).

1. 2006 Medium

   Before its molecular activity was known, the question was whether the NDUFAF7 ortholog had any role in mitochondrial function; the Dictyostelium ortholog MidA was shown to be mitochondrially localized and required for normal ATP production, establishing a conserved mitochondrial bioenergetic role.

   Evidence Gene knockout in Dictyostelium with GFP-fusion localization, ATP and respiration measurements, and 13C-NMR metabolomics

   PMID:16507593

   Open questions at the time

   • No molecular activity or substrate identified at this stage
   • Phenotype is pleiotropic and does not pinpoint complex I
   • Single organism, single lab
2. 2013 High

   The biochemical activity was unresolved until NDUFAF7 was identified as a matrix protein methyltransferase that symmetrically dimethylates Arg-85 of NDUFS2 early in complex I assembly, defining its molecular function and substrate.

   Evidence Mass spectrometry identification of the methylated residue, subcellular fractionation, and in vitro methyltransferase assay

   PMID:24089531

   Open questions at the time

   • Causal requirement for assembly not yet tested by loss-of-function
   • Structural basis of catalysis unknown
   • Timing relative to subcomplex formation inferred
3. 2014 High

   It was unclear whether methylation was functionally required for complex I biogenesis; loss-of-function across organisms and an active-site mutant showed that NDUFAF7 catalytic activity stabilizes an early intermediate and is essential, with AFG3L2-mediated degradation of ND1 upon its loss.

   Evidence siRNA in human fibroblasts, zebrafish morpholino, mouse germline disruption, reciprocal anti-ND1 IP/MS, and expression of the G124V methyltransferase-dead mutant

   PMID:24838397

   Open questions at the time

   • Mechanism coupling methylation to intermediate stability not structurally defined
   • How AFG3L2 selects ND1 not addressed
   • Order of methylation versus other assembly steps incompletely resolved
4. 2017 Medium

   The disease relevance of NDUFAF7 dysfunction was probed by a missense variant (D266E) that impairs complex I activity, reduces ATP, and mislocalizes the protein, connecting loss of function to mitochondrial bioenergetic failure.

   Evidence Variant identification by Sanger sequencing with immunofluorescence localization, immunoblotting, and complex I/ATP biochemical assays

   PMID:28837730

   Open questions at the time

   • Does not dissect effect on methyltransferase catalysis directly
   • Single variant, single lab
   • Genotype-phenotype link not established in a patient cohort
5. 2018 High

   The structural and mechanistic basis of substrate handling was unknown; crystal structures of MidA revealed a methyltransferase core plus a regulatory loop domain and showed that methylation weakens substrate binding, defining a methylation-triggered substrate-release mechanism conserved across evolution.

   Evidence X-ray crystallography of MidA, pre/post-methylation NDUFS2 binding assays, bioinformatic conservation analysis, and in vivo rescue in Dictyostelium

   PMID:30134162

   Open questions at the time

   • No structure of the human NDUFAF7 protein or its complex with human NDUFS2
   • How the regulatory loops select ligands not fully defined
   • Coupling of release to downstream assembly steps not visualized

• How NDUFAF7 is recruited to the nascent complex I intermediate, how its release is coordinated with subsequent assembly steps, and the spectrum of human disease caused by its mutations remain open.
• No human enzyme structure or human enzyme–substrate complex
• Recruitment and timing within the assembly pathway not mechanistically defined
• Patient genetic and clinical spectrum not established in the corpus